Evidence map›Paper›PMID 31488411›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2019

Kirsten A M White, Yvonne T Dailey, Dolores D Guest, Kate Zielaskowski, Erika Robers, Andrew Sussman, Keith Hunley, Christopher R Hughes, Matthew R Schwartz, Kimberly A Kaphingst and 3 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Kirsten A M WhiteDepartment of Internal Medicine, University of New Mexico, Albuquerque, New Mexico.
Yvonne T DaileyDepartment of Internal Medicine, University of New Mexico, Albuquerque, New Mexico.
Dolores D GuestComprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico.
Kate ZielaskowskiDepartment of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.
Erika RobersComprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico.
Andrew SussmanComprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico.
Keith HunleyDepartment of Anthropology, University of New Mexico, Albuquerque, New Mexico.ORCID 0000-0003-0987-8277
Christopher R HughesDepartment of Biology, University of New Mexico, Albuquerque, New Mexico.
Matthew R SchwartzComprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico.ORCID 0000-0001-9563-5727
Kimberly A KaphingstCommunication Department, University of Utah, Salt Lake City, Utah.
David B BullerKlein Buendel, Inc., Golden, Colorado.
Jennifer L HayDepartment of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.
Marianne BerwickDepartment of Internal Medicine, University of New Mexico, Albuquerque, New Mexico. mberwick@salud.unm.edu.ORCID 0000-0001-5062-2180
University of New Mexico · USMemorial Sloan Kettering Cancer Center · USKlein Buendel (United States) · USUniversity of Utah · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Sex Differences in Methylome Alterations and Mutational Burden in Early Stage MelanomaP01CA206980 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BERWICK, MARIANNE, THOMAS, NANCY E. · 2017 to 2022
$10.1M
Psychosocial Palliative & Community Research in CancerT32CA009461 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JENNIFER L HAY, Jamie S. Ostroff · 1985 to 2026
$10.1M
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and ReachR01CA181241 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BERWICK, MARIANNE, HAY, JENNIFER L · 2014 to 2016
$2.1M
NCI NIH HHS P01 CA206980NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA181241NCI NIH HHS T32 CA009461
6 · The paper itself

Abstract

backgroundThe Melanocortin 1 Receptor (

methodsWe genotyped

resultsWe found that one

conclusionsThe R163Q variant in IMPACT: Genetic risk cannot be extrapolated from Northern European populations directly to non-European populations.

Indexed as

Genetic VariationGenotypeHumansNew MexicoReceptor, Melanocortin, Type 1MC1R protein, humanReceptor, Melanocortin, Type 1

Identifiers

PMID31488411
PMCPMC6825590
OpenAlexW2972155510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.